Cochlear Limited Cochlear Limited

Cochlear Limited

COH

Rang in aandelen #2874
Globally, Cochlear Limited specializes in the development and provision of... Globally, Cochlear Limited specializes in the development and provision of implantable auditory solutions for both children and adults. The company's diverse offerings include advanced cochlear implant systems, upgrades for sound processors, bone conduction devices, and a wide array of accessories and other related items. Established in 1981, its global operations are directed from its headquarters in Sydney, Australia.
Aandeelprijs
$99.35
Marktkapitalisatie
$6.50B
Verandering (1 dag)
0.55%
Verandering (1 jaar)
-46.93%
Land
AU
Handel Cochlear Limited (COH)

Categorie

Healthcare
Winst voor Cochlear Limited (COH)
Winst in Jun 2026 TTM: $150.86M
Volgens de meest recente financiële verslagen van Cochlear Limited bedraagt de huidige winst van het bedrijf $150.86M. In 2024 behaalde het bedrijf een winst van $323.70M, een stijging ten opzichte van de winst van 2023, die $264.38M bedroeg. De weergegeven winst op deze pagina is de winst vóór rente en belastingen, oftewel EBIT.
Winstgeschiedenis van Cochlear Limited van 2000 tot 2026
Winst aan het einde van elk jaar
Jaar Winst Wijzigen
2026 (TTM) $150.86M -55.80%
2025 $341.33M 5.45%
2024 $323.70M 22.44%
2023 $264.38M -2.66%
2022 $271.62M -0.34%
2021 $272.55M -246.35%
2020 $-186.23M -172.53%
2019 $256.76M 1.81%
2018 $252.18M 6.05%
2017 $237.79M 25.54%
2016 $189.42M 25.33%
2015 $151.14M 36.82%
2014 $110.47M -29.98%
2013 $157.76M 113.92%
2012 $73.75M -70.75%
2011 $252.13M 42.20%
2010 $177.30M 24.31%
2009 $142.62M -5.13%
2008 $150.33M 23.40%
2007 $121.83M 50.73%
2006 $80.83M 41.91%
2005 $56.96M 73.56%
2004 $32.82M -38.83%
2003 $53.65M 86.61%
2002 $28.75M 21.74%
2001 $23.62M 24.54%
2000 $18.96M 0.00%
Winst van vergelijkbare bedrijven of concurrenten
Bedrijf Winst Winstverschil Land
$7.51B 4,878.77%
US
$5.56B 3,587.51%
IE
$5.15B 3,312.43%
US
$3.86B 2,459.32%
US
- -
DE